loadpatents
Patent applications and USPTO patent grants for Pathway Therapeutics Inc..The latest application filed is for "(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases".
Patent | Date |
---|---|
Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy Grant 8,486,939 - Rewcastle , et al. July 16, 2 | 2013-07-16 |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 8,461,158 - Rewcastle , et al. June 11, 2 | 2013-06-11 |
(alpha-substituted Aralkylamino And Heteroarylalkylamino) Pyrimidinyl And 1,3,5-triazinyl Benzimidazoles, Pharmaceutical Compositions Thereof, And Their Use In Treating Proliferative Diseases App 20120252802 - Brown; S. David ;   et al. | 2012-10-04 |
SEC | 0001498495 | Pathway Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.